Tg Therapeutics (TGTX) Depreciation and Depletion (2011 - 2023)

Tg Therapeutics' Depreciation and Depletion history runs 13 years deep, the most recent figure standing at $73000.0 for Q3 2023.

• On a quarterly basis, Depreciation and Depletion fell 3.95% year-over-year to $73000.0 in Q3 2023; TTM through Sep 2023 was $246000.0, a 20.65% decrease from a year earlier, with the FY2022 full-year figure at $303000.0, up 7.45% from the prior year.
• Depreciation and Depletion rose to $73000.0 in Q3 2023 per TGTX's latest filing, from $32000.0 in the prior quarter.
• Across five years, Depreciation and Depletion topped out at $80000.0 in Q4 2021 and bottomed at $23000.0 in Q1 2019.
• The 5-year median for Depreciation and Depletion is $59000.0 (2021), against an average of $53473.7.
• Across the five-year window, Depreciation and Depletion jumped 97.06% in 2021 and sank 58.97% in 2023, its largest moves.
• Year by year, Depreciation and Depletion stood at $28000.0 in 2019, then soared by 89.29% to $53000.0 in 2020, then jumped by 50.94% to $80000.0 in 2021, then fell by 8.75% to $73000.0 in 2022, then changed by 0.0% to $73000.0 in 2023.
• Per Business Quant, the three latest TGTX Depreciation and Depletion figures stand at $73000.0 (Q3 2023), $32000.0 (Q2 2023), and $68000.0 (Q1 2023).